|
Radiological Features
|
|
|
| Bilateral perihilar streaking[@34593] |
1 |
1(0.2%) |
| Ground glass opacities[@34573; @34577; @34592; @34599; @34603; @34604; @34607; @34621] |
8 |
12(2.9%) |
| Consolidation[@34573; @34589; @34604] |
3 |
3(0.7%) |
| Patchy fuzzy shadows[@34614] |
1 |
1(0.2%) |
| Bilateral streaky infiltrates[@34606] |
1 |
1(0.2%) |
| Pneumothorax[@34615] |
1 |
1(0.2%) |
| Reduced lung volume[@34575; @34592] |
2 |
2(0.5%) |
| Thickened lung texture[@34578] |
1 |
1(0.2%) |
| Diffuse haziness[@34612] |
1 |
1(0.2%) |
| Mild pulmonary infection[@34615; @34616] |
2 |
2(0.5%) |
| Pneumonia[@34612; @34613] |
2 |
4(1.0%) |
| RDS[@34610; @34615; @34618] |
3 |
4(1.0%) |
| Bronchovascular shadows[@34615; @34621] |
2 |
2(0.5%) |
| Increased Lung markings[@34608] |
1 |
3(0.7%) |
|
Laboratory Features
|
|
|
| Elevated WBC count[@34607; @34613; @34617; @34622] |
4 |
10(2.4%) |
| Abnormal LFT[@34578; @34593; @34615] |
3 |
4(1.0%) |
| Elevated Cytokines[@34573; @34618; @34622] |
3 |
3(0.7%) |
| Elevated Creatine Kinase[@34578; @34602; @34611; @34613; @34618] |
5 |
9 (2.2%) |
| Lymphopenia[@34578; @34586; @34606; @34612; @34623] |
5 |
6(1.4%) |
|
Treatment
|
|
|
| Antiviral[@34571; @34579; @34589; @34593; @34616] |
5 |
9(2.2%) |
| Interferon[@34607; @34614] |
2 |
4(1.0%) |
| Antibiotics[@34571; @34573; @34575; @34578; @34579; @34589; @34591; @34593; @34594; @34599; @34600; @34602; @34603; @34607; @34609; @34610; @34612; @34613] |
18 |
23(5.5%) |
| Oxygen/ventilation[@34573; @34574; @34575; @34589; @34593; @34595; @34598; @34599; @34600; @34601; @34603; @34606; @34610; @34613; @34617; @34618; @34619] |
17 |
22 (5.3%) |